A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/7088 (2006.01) A61K 38/18 (2006.01) A61K 39/395 (2006.01) A61K 45/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2519875
Methods of regressing or inhibiting a tumor in a subject by administering an agent capable of blocking, inhibiting, or ameliorating vascular endothelial growth factor (VEGF)-mediated activity to a subject in need thereof such that the tumor is regressed or inhibited. The method of the invention results in a reduction of tumor size and inhibition of tumor metastases. This method is particularly useful for patients suffering from bulky, metastatic cancers.
L'invention concerne des méthodes de régression ou d'inhibition d'une tumeur chez un sujet par le biais de l'administration d'un agent capable de bloquer, d'inhiber ou d'améliorer l'activité de médiation du facteur de croissance de l'endothélium vasculaire (VEGF) chez un sujet le nécessitant, de telle manière que la tumeur régresse ou est inhibée. Ladite méthode de cette invention débouche sur une diminution de la taille de la tumeur ou sur l'inhibition des métastases tumorales, et elle est particulièrement utilisée avec des patients souffrant de cancers métastatiques, volumineux.
Holash Jocelyn
Huang Jianzhong
Kandel Jessica
Rudge John
Yamashiro Darrell
Blake Cassels & Graydon Llp
Regeneron Pharmaceuticals Inc.
The Trustees Of Columbia University In The City Of New York
LandOfFree
Method of tumor regression with vegf inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of tumor regression with vegf inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of tumor regression with vegf inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1534840